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Conclusions: PBC calculates hot spot dose-volume less accurate than 
AAA in HT tissues. Therefore hot spot information is not precise in PBC 
plans than AAA plans and max dose constrains could be above than 
intended. Additionally, PBC could calculate OAR doses less than 
actual, which might cause over doses and morbidity in some OARs, 
such as spinal cord. Consequently AAA should be preferred to PBC for 
target including HT such as lung.  
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Purpose/Objective: More accurate and complex radiation techniques 
are required in order to improve the dose distribution over the target 
volume while sparing organs at risk. The development of new dose 
calculation algorithms which are both more accurate and faster than 
those used in clinical routine is required. Along with statistical 
methods like reduced (fast) Monte Carlo, we propose an alternative 
method based on a deterministic approach which provides advantage 
in reduced cost and improved precision. 
Materials and Methods: Our deterministic algorithm is based on the 
solution of Fokker Planck equation by using the multi-group in energy 
method combined with a specific angular momentum closure. For 
each energy-group, the equations for 2 angular moments are closed 
with the algebraic relation deduced from the principle of entropy 
minimization. (1) 
This method is already implemented in the plasma physics community 
for description of the energetic electron and photon transport 
combining good efficiency and precision. CELIA laboratory has 
developed a computing platform dedicated for validation of this 
algorithm for medical applications validation. Two aspects are 
considered : dose deposition calculation and optimization of the 
treatment plans. 
(1) Dubroca, Feugeas, Frank, Angular moment model for the Fokker-
Planck equation, Eur. Phys. J. D 60 (2010) 301–307 
Results: This deterministic code is compared to direct Monte-Carlo 
simulations using Geant4 and Penelope in the case of homogeneous 
and heterogeneous phantoms (water and bone media). It shows good 
precision in dose deposition and very short calculation time. We also 
present the results of an experimental campaign of sources 
characterizations on linear medical accelerators (energy spectrum). 
These data were implemented in the code for dose calculations. 
Conclusions: This work is the result of a multidisciplinary and 
transversal collaboration involving laboratories in fundamental 
physics, applied mathematics and cancer centers in the framework of 
a regional project with European financial grants started in 2011.  The 
promising results obtained for electrons transport will be further 
extended to photons. The algorithm in dose optimization process is 
now under development. 
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Purpose/Objective: The wedge remains the most frequently used 
beam modifying device in non-IMRT treatments. In ELEKTA linacs, a 
fixed angle mechanical wedge is placed in the head; arbitrary wedge 
angles can be achieved by using the wedge for part of the treatment. 
In this technique (called motorized wedge),only one wedge direction 
is provided; this direction is orthogonal to the leaves’ direction in the 
multileaf collimator (MLC). As a result, concomitant use of MLC and a 
wedge can lead to conflicts with the optimal collimator angle. In 
addition, the motorized wedge technique results in a high number of 
monitor units (MU), producing a significant amount of scatter dose. To 
overcome these problems, ELEKTA provides the OmniWedge 
system,which makes use of the motorized wedge and a dynamic 
wedge. The OmniWedge is a built-in mode in the PrecisePlan 
Treatment Planning System (TPS). The purpose of this work is to 
present the commissioning of the system. 
Materials and Methods: We measured wedge factors and dose profiles 
as function of depth, field size, wedge angle and wedge orientation. 
The measurements were performed for the Elekta PreciseTM linac 
equipped with 6 and 18MV photon energies, at a fixed SSD = 100cm. 
Wedge factor measurements were done in a solid water phantom 
RMI457 using a Farmer 2571 ion chamber and a PTW Unidos 
electrometer. Because the dynamic wedge was of particular interest, 
wedge factors for this option (i.e. OmniWedge oriented by 900 ) were 
measured for field sizes 5x5,10x10, and 15x15 cm2, wedge angles of 
15o, 30o, and 45o, at depths of 5, 10, and 15 cm. For other OmniWedge 
orientations, fewer beams were selected to reduce workload. Profile 
measurements were done for 9 different combinations of wedge 
angles and orientations, field sizes and depths using the IBA I‘mRT 
MatriXX system. TPS calculation accuracy was verified by comparison 
of measured and calculated doses. 
Results: The ratio between the measured and calculated wedge 
factors (WFM/WFC) was derived. For the dynamic wedge mode, the 
ratio WFM/WFC was in the range 0.99 to 1.01 for both energies. For the 
OmniWedge mode, the results were less consistent but the 
discrepancy remained less than4%. Profiles comparisons between 
measured and calculated ones were also performed. In general, the 
differences between the profiles are subtle in the central region and 
get bigger at the edges of the fields. 
Conclusions: Comparison of measured and calculated data showed 
high correspondence between the two. In light of the above,we have 
successfully implemented the OmniWedge technique in our 
department. The use of OmniWedge offers the benefit of optimal 
collimator angle and fewer MUs needed for many usual cases. 
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Purpose/Objective: Trustworthy checks of TPS calculated dose values 
are workaday life in medical physics routine of every radiotherapy 
department. 3D treatment planning is more and more complex. And 
due to quality assurance (QA) requirements1 a TPS independent 
calculation proof of correct monitor units (MU) is obligatory. 3D TPS 
plans for Elekta® and Varian® linacs use static, motorized and dynamic 
wedges. Treatment plans contain excentric irregular fields where the 
normalization point is not identical to the geometric isocenter. An 
easy to use method based on dosimetric measurements of linac beam 
parameters are implemented to realize QA monitor unit checks of 
complex 3D plans. In particular it is important to assure that on the 
minimal open field dimension of tiny volumes of interest (VOI) the 
calculated MU is within an acceptable range. 
Materials and Methods: Basic dosimetric measurements of wedge 
accessories are used to derive parameters for an innocent 
interpolation function for field MU value QA. All depth dose curve 
measurements along the wedge shape are used in a two-dimensional 
non-linear fit for valid parameters. The quality of the results is 
evaluated in terms of benign trends using slight extrapolations with 
tiny field dimensions of about 1cm2. Embedded JavaScript® in PDF 
documents is used to generate a well accepted procedure in daily 
workflow2 for routine medical physics QA. The master document is 
generated by utilizing LaTeX® with extensions hyperref3 and insdljs4. 
Results: Within this paper an implementation based directly on linac 
dosimetric measurements is described. Resulting non-linear 
parametric fits with few parameters have been proved to be innocent 
even beyond the borders for limited extrapolation. This is important 
especially for high dose hypo-fractionated stereotactic treatment 
procedures based on multi-fields (≥10) and effective field areas of 
≈1cm2. Within our clinical routine workflow this form-based method is 
very well accepted and integrates seamless into electronic 
patientfolder of ROKIS5 while documenting continuous treatment 
related QA. 
Conclusions: The long term evaluationof an JavaScript and PDF-
Document based implementation via LaTeX® is presented. The 
interactive tool is now in daily operation for more than two years 
resulting in >5000 final MU dose check documents.The discussion part 
of the paper also covers 'easy to use' arguments and the problem of 
legal issues rising from departement internal software tools. 
1. Fraass et al.; Task Group 53 report on quality assurance 
Med. Phys., Vol. 25, No. 10, October 1998; p.1773-1829 
2. Heinemann F, Röhner F, et al.: [Department and Patient 
Management in Radiotherapy. The Freiburg Model] 
Strahlentherapie und Onkologie, Volume 185, Issue 3, p.143-54 
3. hyperref: Hypertext marks in LATEX 
http://www.tug.org/applications/hyperref/manual.html 
4. insdljs: Insert document-level JavaScript in LaTeX documents 
http://www.ctan.org/tex-archive/info/pdf-forms-
tutorial/de/forms.pdf 
5. DGMP Report nr. 20 of the German Society of Medical Physics 
http://www.dgmp.de/oeffentlichkeitsarbeit/papiere/Bericht20.pdf  
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Purpose/Objective: Be able to know the real dosimetry inside the 
patients is very important to know the accuracy provided by the 
Treatment Planning Systems (TPS) and at the same time it is very 
difficult to realize. To evaluate the dosimetry in a realistic manner 
without resorting to a real patient, anthropomorphic phantoms can be 
used. . In this work, we have evaluated the calculations provided by 
the TPS Eclipse V10 with AAA algorithm in the pelvic area of a RANDO 
Man© anthropomorphic phantom for prostate treatments, assessing 
the measures through the use of termoluminiscent detectors (TLDs) 
with the data provided by the planner in PTVs as well as in various 
organs of risk.  
Materials and Methods: 4 prostate treatments, 2 low risk cases (PTV-
T to 7000cGy in 30 fractions) and 2 high risk cases with nodal chain 
irradiation (PTV-T to 7000cGy and PTV-N to 5040 in 30 fraction)) were 
planned using a Eclipse V10 with AAA algorithm and irradiated in a 
VARIAN 2300 iX linear accelerator, equipped with Millenium 120 MLC. 
PTVs and OARs were delineated in the previously scanned phantom. 
All treatment plans consisted of a single VMAT field, 6 MV X-rays, full 
rotation and 30º of collimator rotation. Dose was prescribed to the 
median PTV dose, requiring that more than 98% of the PTV volume 
should receive at least 95% of the prescribed dose, and no more than 
2% of the PTV volume should exceed 107% of the prescribed dose. 
Organs at risk fulfilled the departments’ constraints. A set of 100 TLDs 
(Harshaw XD-100 extremity (EXT-RAD) model) was used in order to 
calibrate, background measures, and PTVs and Organs At Risk (OARs) 
measurements.  
Results: The results of the TLDs dose measurements are summarized 
in the Table 1.And the absolute desviations for all the measurements 
is presented in Figure 1.Regarding with the high dose low gradient 
region, the average dose difference was -1.5% ± 4.6% (1 SD) for the 
PTV-T and -0.3% ± 4.5% for the PTV-N. The average OARs dose 
difference is below 2.5% for all of them. The standard deviation of the 
OARs is significantly higher than the corresponding to the PTVs. A 
plausible explanation is that the TLD have a size of about 3 mm, and 
are located in regions of high dose gradients. Also must be taken into 
account that small variations of the TLD position have a great impact 
on its dose measurement or calculation. Although the analysis done in 
this work was focused on the prostate, it is equally applicable to the 
rest of pathologies involved in the pelvis or abdominal area, because 
the type of heterogeneities is quite similar. 
 
Table 1: Number of measurements for each location and mean
result in %  
Location Number ofmeasurements 
Mean result (Dcalculated -
Dread)/Dread 
Rectum 10 -0.22% ± 9.7% 
Bladder 4 2.35% ± 3.6% 
Femoral Heads 16 -2.02% ± 6.4% 
Intestinal 
package 2 0.99% ± 8.7% 
PTV-T 11 -1.50% ± 4.6% 
PTV-N 6 -0.27% ± 4.5% 
 
 Conclusions: The use of TLD in conjunction with anthropomorphic 
phantoms is a useful tool to verify the accuracy of the dose 
calculation algorithm implemented in the TPS in realistic anatomical 
cases. We conclude that the AAA algorithm provides reliable dose 
calculation for the treatment with VMAT in the anatomy of the pelvis. 
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Purpose/Objective: Step 1 : To validate relative and absolute dose 
calculations of electron Monte Carlo algorithm (Eclipse, eMC 10.0.28, 
Varian) in simple geometry conditions for a set of inserts (rectangle, 
square) used in the clinical routine in a water phantom: profiles, 
percentage depth dose (pdd) and monitor units (MU) calculations. 
Step 2 : To study some dosimetric parameters of eMC calculations for 
boost dose in breast cancer: 1) validation of relative dose and MU 
calculations with obliquities in a water phantom and 2) comparison of 
MU calculated in Step 1 with 13 patient case studies ; first, with mass 
densities of the patients ; second, by assigning 0 UH to the 'body' not 
to take into account internal heterogeneities.  
Materials and Methods: Varian eMC modelling procedure was carried 
out for 7 energies (6MeV, 9MeV, 12MeV, 15MeV,16MeV, 18 MeV and 
20MeV) and 5 applicators (6x6cm2, 10x10cm2, 15x15cm2, 20x20cm2 and 
25x25cm2). Cylindrical and flat ionisation chambers (CC13, PPC40, 
NACP – IBA Dosimetry) were used for relative and absolute dose 
measurements in water. MU were calculated for delivering 1 Gy at the 
maximum depth dose on the beam axis. eMC calculations grid size and 
accuracy were 2 mm and 1%. In step 1, the gantry was perpendicular 
to the water phantom and the surface skin distances were 100cm, 
105cm and 110cm. 
Results: Step 1 : Relative dose measurements including profiles in the 
lateral constriction of 80% isodose curve gave good agreements with 
eMC calculations. The largest differences in pdd at 50% of the 
maximum dose were found at 6 MeV, up to 2.1 mm for a 5x10cm2 
rectangular inlay. Profiles fitted well with differences < 1% of the 
inlay size at 50% of the profile. The largest differences were found 
after the flat floor of the profile on the rounded part (between 98% 
and 90%). We achieved good agreement between MU eMC calculations 
and measurements, resulting in a maximum absolute deviation of 
3.8%, 2.2% and 1.9% respectively for energies of 6MeV, 9MeV and 
12MeV. Step 2 : Differences between MU eMC calculations in patients 
and MU calculated in water in step 1 were slightly higher, resulting 
respectively to 9.2%, 3.5% and 23.3% in mean, minimum and maximum 
deviations. These deviations remained similar when assigning 0 UH to 
the 'body' of the patients, resulting respectively to 8.1%, 3.5%, and 
21.6%.  
Conclusions: Step 1 : Relative and absolute dose measurements were 
found to be accurate enough for a clinical use of eMC. Step 2: 
significant differences were identified between UM measurements in 
water (step 1) and eMC calculations in patients both with mass 
densities of the patients or by assigning 0 UH to the 'body'. Beam 
obliquity relative to the patient surface was found to be one of the 
main parameter that could explain this deviation (as far as 
prescription point was at the maximum pdd in a soft tissue).  
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Purpose/Objective: Independent verification of the monitor unit (MU) 
calculation for radiotherapy is important to ensure the accuracy of 
the dose calculation in the treatment planning system (TPS). In2011, 
task group 114 (TG-114) of the American Association of Physicists in 
Medicine published a report for use as a guideline for verifying the MU 
calculation. We consider the clinical use of an independent MU 
calculation software (EqualDose v 4.0) that was developed by a 
project of the European Society for Radiotherapy and Oncology. We 
have evaluated the accuracy of dose calculation by this MU calculation 
software on the basis of the TG-114 report. 
Materials and Methods: Verification plans in a homogeneous phantom 
were modeled in the TPS (Xio, Elakta Oncology Systems and 
Eclipse,Varian Medical Systems), including open, physical wedge, 
dynamic wedge, and multi-leaf collimator fields. We selected an 
evaluation point within the phantom at the isocenter and off-axis 
point. Superposition (SP), Convolution (CO), Clarkson (CL), Analytical 
Anisotropic Algorithm (AAA), and Pencil Beam Convolution (PBC) 
